News | Computed Tomography (CT) | November 23, 2015

University of Wisconsin Carbone Cancer Center Adopts BodyTom for Brachytherapy Treatment

First center in the world to use BodyTom in the brachytherapy suite

CT scan

Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. and a leading provider of advanced imaging solutions, announced today that the University of Wisconsin (UW) Carbone Cancer Center in Madison acquired and is incorporating NeuroLogica’s BodyTom technology into its radiation oncology brachytherapy planning process. UW Carbone Cancer Center is the first center in the world to use the BodyTom scanner for brachytherapy treatment.

The BodyTom CT further distinguishes UW Carbone Cancer Center, the state’s only National Cancer Institute-certified comprehensive cancer center that recently landed 15 physicians on Newsweek’s “Top Cancer Doctors 2015” list.The 32-slice portable CT scanner will be stationed in the brachytherapy suite, enabling patients to undergo radiation imaging, planning and treatment in a single location.

"Having in-room, high-quality CT imaging removes the need for patient transfer while under anesthesia during the procedure to a separate CT suite, and provides opportunities for pre- and post-implant quality assessment," said Greg Cooley, M.D., "and we can use the BodyTom CT in both of our suites without duplication of equipment for each room."

Radiation oncologists at UW Carbone Cancer Center use high-dose-rate (HDR) brachytherapy to treat forms of prostate, breast, gynecological and lung cancers. Radioactive sources are temporarily inserted inside tumors or areas of interest; this process enables precise delivery of high doses in a short time. The BodyTom produces high-quality, 3-D images to aid this process and can also be used to double-check the placement of radioactive implants, and make adjustments as necessary, without moving the patient.

“Hospital departments across the country recognize the value BodyTom can bring to patient care and efficient work practices,” said Philip Sullivan, Samsung NeuroLogica president and CEO. “Bringing BodyTom into the brachytherapy suite, especially one as well respected as UW’s Carbone Cancer Center, is a testament to BodyTom’s versatility.”

For more information: www.SamsungNeuroLogica.com.

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve